Daniel Gaudet (19 results)

Condition: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

Paperback. Condition: Good. No Jacket. Former library book; Pages can have notes/highlighting. Spine may show signs of wear. ~ ThriftBooks: Read More, Spend Less.

Paperback. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

paperback. Condition: New. pristine condition. In stock.

Condition: Good. paperback 100% of proceeds go to charity! Good condition with all pages in tact. Item shows signs of use and may have cosmetic defects.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

HRD. Condition: New. New Book. Shipped from UK. Established seller since 2000.

Condition: New.

Hardback. Condition: New.

Condition: Very Good. : Esta guía musical, catalogada para todos los pianistas, es una obra exhaustiva que incluye una discografía y referencias bibliográficas. Ofrece una visión completa de la música para piano, abarcando desde aficionados hasta estudiantes avanzados de conservatorios. Escrita por Catherine Lechner-Reydellet en colaboración con Daniel Gaudet, y con un prólogo de Alain Jacquon, es una herramienta valiosa para cualquier pianista. EAN: 9782840494195 Tipo: Libros Categoría: Arte y Cultura Título: Guide musical répertorié à l'usage de tous les pianistes Autor: Catherine Lechner-Reydellet| Daniel Gaudet Editorial: SEGUIER Idioma: fr-FR Páginas: 233 Formato: tapa blanda.…

paperback. Condition: New. 1st.

Hardback. Condition: New.

Hardcover. Condition: New.

Condition: New. Print on Demand.

Condition: New. Print on Demand.

Condition: New. PRINT ON DEMAND.

Hardcover. Condition: new. Hardcover. Cardiovascular disease remains a leading cause of death worldwide, with low-density lipoproteins and other atherogenic lipoproteins, such as lipoprotein remnants, playing a key role in the development of atherosclerosis. Beyond LDL cholesterol, the identification of biological, environmental, and genetic markers associated with remnant metabolism has improved cardiovascular risk prediction and informed treatment strategies. This Reprint examines rare and severe lipid disorders, including homozygous familial hypercholesterolemia, refractory hypercholesterolemia, and severe hypertriglyceridemia, which continue to present major therapeutic challenges despite maximally tolerated lipid-lowering therapies. It also highlights the rapid development of novel inhibitors such as PCSK9, ANGPTL3, and APOC3, as well as emerging therapies derived from new mechanistic pathways. In addition, the link between metabolic conditions such as non-alcoholic steatohepatitis and cardiovascular events is explored. Collectively, the articles in this Reprint provide a comprehensive and up-to-date overview of current advances, ongoing challenges, and future perspectives in lipid modification and cardiovascular risk management. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

Buch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Cardiovascular disease remains a leading cause of death worldwide, with low-density lipoproteins and other atherogenic lipoproteins, such as lipoprotein remnants, playing a key role in the development of atherosclerosis. Beyond LDL cholesterol, the identification of biological, environmental, and genetic markers associated with remnant metabolism has improved cardiovascular risk prediction and informed treatment strategies. This Reprint examines rare and severe lipid disorders, including homozygous familial hypercholesterolemia, refractory hypercholesterolemia, and severe hypertriglyceridemia, which continue to present major therapeutic challenges despite maximally tolerated lipid-lowering therapies. It also highlights the rapid development of novel inhibitors such as PCSK9, ANGPTL3, and APOC3, as well as emerging therapies derived from new mechanistic pathways. In addition, the link between metabolic conditions such as non-alcoholic steatohepatitis and cardiovascular events is explored. Collectively, the articles in this Reprint provide a comprehensive and up-to-date overview of current advances, ongoing challenges, and future perspectives in lipid modification and cardiovascular risk management.…

Buch. Condition: Neu. Management of Dyslipidaemias | Enhancing Lipid Modification to Reduce Cardiovascular Risk | Buch | Englisch | 2025 | MDPI AG | EAN 9783725856237 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…